A new venture of Mehta Group, state-of-the-art facility conforming to USFDA / CGMP /UK-MHRA/EDQM & TGA standards (Under its newly formed Mehta API Pvt. Ltd.) to manufacture APIs just commissioned.

Spread across a sprawling 26,580 Sq M., this facility will have dedicated blocks for the manufacturing of APIs.

Erythromycin Derivatives, Azithromycine and its Intermediates, Intermediates of Clarithromycin and Dirithromycin.

Multipurpose facility with Kilo Lab/ Pilot Plant to be commissioned shortly

Separate Quality Control and Quality Assurance Departments manned by qualified personnel and backed by a well equipped modern laboratory.

seeks strategic alliance from innovator. Generic & Dossier companies globally for APIs & Advanced Intermediates.